WRTC is proud to partner with various tissue banks and research institutions whose mission and purpose is to save lives through development and implementation of therapies for disease and trauma.

Allosource

Founded in 1994, AlloSource, of Centennial, Colorado is one of the nation’s largest non-profit providers of bone and soft tissue allografts for use in a host of medical treatments. Honoring the gift of donation, AlloSource responsibly develops, processes and distributes life-saving and life-enhancing human tissue for our communities. In respect to those who have consented to the gift of life, AlloSource values these principles: Assuring the highest quality in the tissue provided to our customers;professionalism and integrity in the conduct of our daily business; and remaining sensitive to the public perception of tissue banking and the impact of our actions upon organ and tissue donation. AlloSource provides a variety of bone and soft tissue allografts for several types of surgical procedures. More than 200 different types of allografts are available from AlloSource for orthopedic, spinal, trauma and other applications.

IIAM

Since 1986, the International Institute for the Advancement of Medicine (IIAM) has become one of the largest recovery and placement networks in the world for the acquisition of donated human tissue for medical research and education. IIAM provides a link between humanity and medical discovery:  IIAM honors the wishes of donors and their families wanting to contribute to medical research and education. Simultaneously, IIAM provides researchers with the human tissue needed to find cures for disease, improve treatments and techniques, and develop novel drugs and medical devices.   IIAM works with: Organ procurement organizations,tissue banks, hospitals, hospice programs, funeral directors, mMedical examiners and individual organ and tissue donors in the U.S. by offering donation for research & education.  

Organ Recovery Systems

Organ Recovery Systems envisions a future where innovations in science and technology are linked to balance the disproportion between organ supply and demand.  OPOs play a vital role in our research and development efforts, as they provide the organs that allow us to conduct research focusing on improving organ preservation technology. In return, this program allows OPOs to offer donor families another opportunity to expand the capacity for healing when donation for transplantation is not possible.  By participating in this program, OPOs may extend a family's gift to help multiple patients in the future.  Some examples of the research and testing performed in our lab include: testing of preservation solutions; development of preservation methodologies; determining the limits in warm and cold ischemic times; development of hypothermic and normothermic preservation models; review of organ resuscitation methods; and drug absorption, effectiveness, toxicity, and interaction while organs are being preserved.

LifeNet Health

Founded in 1982 and headquartered in Virginia Beach, VA, LifeNet Health Inc., is a leading biomedical alloengineering organization and organ and tissue donation agency whose mission is saving lives and restoring health. LifeNet Health is a leader in the engineering and processing of dental, cardiovascular, spinal and orthopedic bio-implants and distributes more than 200,000 bio-implants every year to restore health to patients around the world.

National Development and Research Institutes

Founded in 1967, NDRI is a non-profit research and educational organization dedicated to advancing scientific knowledge in the areas of drug and alcohol abuse, treatment and recovery; HIV, AIDS and HCV; therapeutic communities; youth at risk; and related areas of public health, mental health, criminal justice, urban problems, prevention and epidemiology in order to contribute to the prevention and solution of these social problems. NDRI is organized into specialized Institutes, each under the direction of a senior scientist. Each Institute focuses on a particular issue and has its own staff of researchers. NDRI with its large number of grants and contracts, its collaboration with a wide array of hospitals, treatment and prevention programs, its publications in leading journals and scientific books, and its acceptance into communities with diverse ethnic populations, reflects its well established reputation as a unique, highly responsible and productive research organization.

Vesta Therapeutics

Vesta Therapeutics is a privately held company developing cell therapeutics for liver repair and regeneration. The Company's technology is centered on the isolation, expansion, and cryopreservation of liver cells (human hepatocytes) obtained from organ donor livers that are not suitable for whole organ transplantation. Clinicians in academic settings have found that, following administration, human hepatocytes engraft and create new functioning liver tissue, which may provide a bridge to transplant or in some cases, eliminate the need for a liver transplant. The Food and Drug Administration has allowed the Company's Investigational New Drug (IND) application for a Phase I clinical trial of cryopreserved, allogeneic human liver cells for the treatment of patients with cirrhosis and end-stage liver disease.